Avalo Therapeutics (AVTX) Competitors

Avalo Therapeutics logo
$7.80 +0.15 (+1.89%)
As of 02/12/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AVTX vs. CRVS, TRVI, KRRO, TSHA, TNGX, ATAI, KOD, RZLT, NMRA, and ATYR

Should you be buying Avalo Therapeutics stock or one of its competitors? The main competitors of Avalo Therapeutics include Corvus Pharmaceuticals (CRVS), Trevi Therapeutics (TRVI), Korro Bio (KRRO), Taysha Gene Therapies (TSHA), Tango Therapeutics (TNGX), Atai Life Sciences (ATAI), Kodiak Sciences (KOD), Rezolute (RZLT), Neumora Therapeutics (NMRA), and Atyr PHARMA (ATYR). These companies are all part of the "pharmaceutical products" industry.

Avalo Therapeutics vs.

Corvus Pharmaceuticals (NASDAQ:CRVS) and Avalo Therapeutics (NASDAQ:AVTX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations, community ranking and media sentiment.

Corvus Pharmaceuticals has higher earnings, but lower revenue than Avalo Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Corvus PharmaceuticalsN/AN/A-$27.03M-$0.93-5.42
Avalo Therapeutics$1.92M41.56-$31.54MN/AN/A

Corvus Pharmaceuticals presently has a consensus target price of $12.38, indicating a potential upside of 145.54%. Avalo Therapeutics has a consensus target price of $40.00, indicating a potential upside of 420.83%. Given Avalo Therapeutics' higher possible upside, analysts clearly believe Avalo Therapeutics is more favorable than Corvus Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Corvus Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Avalo Therapeutics
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Corvus Pharmaceuticals had 1 more articles in the media than Avalo Therapeutics. MarketBeat recorded 1 mentions for Corvus Pharmaceuticals and 0 mentions for Avalo Therapeutics. Avalo Therapeutics' average media sentiment score of 1.87 beat Corvus Pharmaceuticals' score of -1.00 indicating that Avalo Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Corvus Pharmaceuticals Negative
Avalo Therapeutics Very Positive

Corvus Pharmaceuticals' return on equity of -70.71% beat Avalo Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Corvus PharmaceuticalsN/A -70.71% -45.90%
Avalo Therapeutics N/A -442.16%122.99%

46.6% of Corvus Pharmaceuticals shares are owned by institutional investors. Comparatively, 87.1% of Avalo Therapeutics shares are owned by institutional investors. 31.3% of Corvus Pharmaceuticals shares are owned by company insiders. Comparatively, 0.3% of Avalo Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Corvus Pharmaceuticals received 285 more outperform votes than Avalo Therapeutics when rated by MarketBeat users. Likewise, 61.91% of users gave Corvus Pharmaceuticals an outperform vote while only 33.33% of users gave Avalo Therapeutics an outperform vote.

CompanyUnderperformOutperform
Corvus PharmaceuticalsOutperform Votes
291
61.91%
Underperform Votes
179
38.09%
Avalo TherapeuticsOutperform Votes
6
33.33%
Underperform Votes
12
66.67%

Corvus Pharmaceuticals has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, Avalo Therapeutics has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500.

Summary

Corvus Pharmaceuticals beats Avalo Therapeutics on 10 of the 15 factors compared between the two stocks.

Get Avalo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVTX vs. The Competition

MetricAvalo TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$85.13M$6.99B$5.76B$9.15B
Dividend YieldN/A2.91%5.32%4.00%
P/E RatioN/A4.2459.0214.67
Price / Sales41.56312.25989.2374.81
Price / CashN/A75.4646.0938.87
Price / Book0.845.535.125.00
Net Income-$31.54M$123.50M$113.24M$222.75M
7 Day Performance-6.23%-3.29%-1.43%-1.01%
1 Month Performance11.79%-0.08%4.80%4.04%
1 Year Performance59.67%5.40%25.30%21.71%

Avalo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTX
Avalo Therapeutics
3.7098 of 5 stars
$7.68
+0.3%
$40.00
+420.8%
+58.7%$85.13M$1.92M0.0040Positive News
CRVS
Corvus Pharmaceuticals
1.967 of 5 stars
$5.07
-5.4%
$12.38
+144.1%
+122.0%$325.80MN/A-5.4530Short Interest ↑
TRVI
Trevi Therapeutics
2.7828 of 5 stars
$4.22
+7.1%
$9.31
+120.7%
+128.8%$324.39MN/A-9.5920
KRRO
Korro Bio
1.1557 of 5 stars
$33.50
-1.8%
$144.00
+329.9%
-45.9%$313.90MN/A0.0070Gap Down
TSHA
Taysha Gene Therapies
2.6738 of 5 stars
$1.53
+2.0%
$6.63
+333.0%
-5.3%$313.56M$9.92M2.43180
TNGX
Tango Therapeutics
3.6841 of 5 stars
$2.91
-2.3%
$13.14
+351.6%
-80.1%$312.59M$36.53M-2.4790Short Interest ↓
Analyst Revision
ATAI
Atai Life Sciences
2.6762 of 5 stars
$1.85
+19.4%
$9.00
+386.5%
+35.6%$310.43M$310,000.00-2.2880News Coverage
High Trading Volume
KOD
Kodiak Sciences
4.2927 of 5 stars
$5.82
-9.1%
$8.00
+37.5%
-7.8%$306.25MN/A-1.5990Short Interest ↑
Positive News
Gap Down
RZLT
Rezolute
3.3883 of 5 stars
$5.24
-0.2%
$24.13
+360.4%
+326.3%$303.62MN/A-4.1340Earnings Report
Analyst Forecast
Short Interest ↑
News Coverage
NMRA
Neumora Therapeutics
4.0374 of 5 stars
$1.86
-3.6%
$16.50
+787.1%
-90.6%$300.50MN/A-0.99108News Coverage
ATYR
Atyr PHARMA
2.1958 of 5 stars
$3.57
-7.5%
$19.25
+439.2%
N/A$299.67M$350,000.00-3.8053Short Interest ↑

Related Companies and Tools


This page (NASDAQ:AVTX) was last updated on 2/13/2025 by MarketBeat.com Staff
From Our Partners